Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Method Aligns Data from Tissue Slices Virtually to Expand Possibilities for 3D Analysis

By LabMedica International staff writers
Posted on 22 Aug 2023

When it comes to studying biological tissue, whether from a patient or an animal, a common approach involves surgically removing a portion of the affected tissue for analysis. More...

In laboratories across the globe, technicians meticulously slice the extracted tissue into thin sections, which are then examined under a microscope or subjected to tests that detect specific molecules. These molecular clues can aid in diagnosing conditions, guiding treatments, or even gauging the effectiveness of drugs. However, the process of analyzing each slice is resource-intensive in terms of time, money, and computational capacity. Consequently, researchers and medical professionals are often constrained to studying only a limited number of slices from various parts of the tissue. Adding to the complexity, the act of cutting, processing, and analyzing tissue slices within a lab environment causes them to undergo physical distortions. As a result, accurately understanding how these slices align and fit into the three-dimensional structure of the original tissue becomes challenging. Now, a new method revolutionizes the ability to comprehend the three-dimensional composition of tissues, including tumors or other tissue using data from just a few slices, thus allowing for a much deeper understanding of biological tissue samples.

The new method, named Gaussian Process Spatial Alignment (GPSA) which has been developed by researchers at Gladstone Institutes (San Francisco, CA, USA) has a scope extending beyond tumors, encompassing a wide array of tissues and data derived from tissue slices. This innovative method leverages a two-layer Gaussian process. In the first layer, it aligns the warped two-dimensional tissue slice onto a three-dimensional tissue model. The second layer attributes data collected from the slice, such as activated genes, to each point in the three-dimensional model. This intelligent approach effectively reverses the warping effect, resulting in a precise alignment of the slices. During this process, the GPSA model extrapolates data to fill the gaps between slices, generating a comprehensive three-dimensional "atlas" of the tissue.

A key advantage of GPSA is its versatility. Researchers can construct tissue atlases using data from slices of varying sizes, generated by diverse technologies, and captured at different scales and resolutions. Unlike previous techniques that demanded a predefined three-dimensional framework, GPSA derives this framework solely from the two-dimensional slices when an initial framework isn't available. Additionally, GPSA has the capability to merge multiple types of tissue-slice data, such as genetic activity and cellular structure, into a unified atlas. Furthermore, when applied to slices taken from the same tissue at different time points, GPSA can generate atlases that predict how each location within the tissue evolves over time. This feature could deepen our insights into aging, disease progression, and the development of different tissues within growing organisms. Presently, researchers are engaged in further analyses to further demonstrate the tool’s flexibility. For instance, they have devised an approach that budget-conscious labs can use to determine the minimum number of tissue slices required and the precise cutting locations needed for GPSA to build an informative tissue atlas.

“Say you have four slices from different locations in a person’s breast cancer tumor, and for every point on each slice you know which of 20,000 genes are turned on or off,” said Gladstone Senior Investigator Barbara Engelhardt, PhD, senior author of the study. “GPSA creates a fully query-able 3D atlas where, for any single ‘x, y, z’ coordinate, for any of the 20,000 genes, we can dive in and ask: What genes are on and off at this position in the tumor? And how certain are we in this estimate?”

Related Links:
Gladstone Institutes


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
Laboratory Software
ArtelWare
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Colorectal cancer under the microscope (Photo courtesy of Adobe Stock)

Unique Microbial Fingerprint to Improve Diagnosis of Colorectal Cancer

Colorectal cancer is the fourth most common cancer in the UK and the second deadliest. New research has revealed that it carries a unique microbial fingerprint, which could help doctors better understand... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.